CDK4 and neoplasm: Hypermethylation of the RB promoter inactivates the signalling pathway and affects the response of tumour cells to CDK4/6 inhibitors.35,36 The expression of p16/CDKN2 produces p16 protein that inhibits CDK4/6 and halts the cell cycle.